Evidence for Common Clonal Origin of Multifocal Lung Cancers
Authors:
- Mingsheng WangMWMingsheng Wang
- Gregory T. MacLennanGMGregory T. MacLennan
- Fadi W. Abdul-KarimFAFadi W. Abdul-Karim
- John N. EbleJEJohn N. Eble
- Timothy D. JonesTJTimothy D. Jones
- Felix OlobatuyiFOFelix Olobatuyi
- Rosana EisenbergRERosana Eisenberg
- Oscar W. CummingsOCOscar W. Cummings
- Shaobo ZhangSZShaobo Zhang
- Antonio Lopez-BeltranALAntonio Lopez-Beltran
- Rodolfo MontironiRMRodolfo Montironi
Open Access
- 15 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 101 (8) , 560-570
Abstract
Lung cancer is the most common cause of cancer death in the United States. Multiple anatomically separate but histologically similar lung tumors are often found in the same patient. The clonal origin of multiple lung tumors is uncertain. We analyzed 70 lung tumors from 30 patients (23 females and seven males) who underwent surgical resection for lung epithelial tumors, of whom 26 had non–small cell carcinomas and four had carcinoid/atypical carcinoid tumors. All patients had multiple tumors (two to five) involving one or both lungs. Genomic DNA was extracted from paraffin-embedded tissue sections using laser capture microdissection and analyzed for loss of heterozygosity, TP53 mutations, and X-chromosome inactivation status. The percentage (95% confidence interval [CI]) of patients in whom there were concordant patterns of genetic alteration was calculated. All 30 case subjects showed loss of heterozygosity (LOH) in at least one and at most four of the six polymorphic microsatellite markers. Completely concordant LOH patterns between synchronous and metachronous cancers in individual patients were seen in 26 (87%) of 30 informative patients (95% CI = 75% to 99%). Identical point mutations were present in eight of 10 patients who exhibited TP53 mutation by sequencing. Tumors in 18 (78%) of 23 female patients (95% CI = 67% to 98%) showed identical X-chromosome inactivation patterns. Combining the results of LOH studies, TP53 mutation screening analyses, and X-chromosome inactivation data, we demonstrated that the multiple separate tumors in 23 (77%) of 30 patients (95% CI = 62% to 92%) had identical genetic changes, consistent with monoclonal origin of the separate tumors. Our data indicate that the great majority of multifocal lung cancers have a common clonal origin and that multifocality in lung cancer represents local and regional intrapulmonary metastasis.Keywords
This publication has 43 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Clonality and Prognostic Implications of p53 and Epidermal Growth Factor Receptor Somatic Aberrations in Multiple Primary Lung CancersClinical Cancer Research, 2007
- Molecular Evidence for Independent Origin of Multifocal Neuroendocrine Tumors of the Enteropancreatic AxisCancer Research, 2006
- The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centreEuropean Journal of Surgical Oncology, 2004
- Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladderCancer, 2004
- Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung CancersThe American Journal of Pathology, 2000
- p53 Mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinomaCancer, 1999
- Operative approach for multiple primary lung carcinomasThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Synchronous primary lung cancers: prevalence in surgical material and clinical implications.Thorax, 1993
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976